Eickenhorst joins EMD Serono as US CMO
This article was originally published in Scrip
Executive Summary
EMD Serono, a subsidiary of Merck KGaA, has made Dr Thorsten Eickenhorst US chief medical officer and head of US development. Previously, Dr Eickenhorst served as vice-president of clinical development and medical research at Biogen Idec.